Добро пожаловать в клуб

Показать / Спрятать  Домой  Новости Статьи Файлы Форум Web ссылки F.A.Q. Логобург    Показать / Спрятать

       
Поиск   
Главное меню
ДомойНовостиСтатьиПостановка звуковФайлыДефектологияКнижный мирФорумСловарьРассылкаКаталог ссылокРейтинг пользователейЧаВо(FAQ)КонкурсWeb магазинШкольникамКарта сайта

Поздравляем!
Поздравляем нового Логобуржца Королёва со вступлением в клуб!

Реклама

КНИЖНЫЙ МИР

Bioequivalence Study of Antihyperlipidemic in Human Volunteers   Nilesh Wagh,Amit Bhople and Anup Thakre

Bioequivalence Study of Antihyperlipidemic in Human Volunteers

100 страниц. 2012 год.
LAP Lambert Academic Publishing
Finofibrate is an oral antihyperlipemic agent. In this investigation, we report randomized, single dose, open-label, three-treatment, three-period, three-sequence, crossover Clinical study in healthy 18 adult male human volunteers evaluating the bioequivalence of two new investigational formulation of Finofibrate 145 mg Tablets (manufactured by manufactured by Wockhardt Limited, India) and reference formulation ‘Finofibrate ® ‘145 mg Tablet (® indicates reference formulation). In this investigation, we report randomized, single dose, open-label, three-treatment, three period, three-sequence, crossover Clinical study evaluating the bioequivalence of two new investigational formulation of Finofibrate 145 mg Tablets (manufactured by manufactured by Wockhardt Limited, India) and reference formulation ‘Finofibrate ® ‘145 mg Tablet (® indicates reference formulation). Pharmacokinetic parameters were investigated and statistical analysis was done.
 
- Генерация страницы: 0.05 секунд -